Integra LifeSciences Holdings (IART) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.

Total Assets Chart for Integra LifeSciences Holdings

Integra LifeSciences Holdings (IART) total assets for FY2025 were USD 3.6B, a -10.8% change from FY2024. Integra LifeSciences Holdings's total assets grew from USD 19.4M in 1995 to USD 3.6B in 2025 (18467.0% over 30 years). Total assets compound annual growth rate: 5-year CAGR of -0.1%, 10-year CAGR of 7.3%, 20-year CAGR of 11.0%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$926.27M
Implied Share Price
$11.91
Enterprise Value
$3.02B
Revenue (TTM)
$1.66B
EBITDA
$311.51M
Profit Margin
0.79%
Trailing P/E
70.06
Forward P/E
6.00
Price/Book (MRQ)
1.19
Price/Sales (TTM)
0.56
EV/EBITDA
12.32
EV/Revenue
1.83
Dividend Yield
—
Book Value
$13.41
Free Cash Flow (FY2025)
-$45.25M
Free Cash Flow Yield
-4.89%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.